Table 1.
Characteristics of studies included in the severity cohort analysis
| Study | Country & City | Sample Size | Severe patients | Non-severe patients | ||||||
| n (%) | Age (yrs) | Women (%) | AKI (%) | n (%) | Age (yrs) | Women (%) | AKI (%) | |||
| Guan et al. [4] | Outside Hubei, China | 1099 | 173 (15.7%) | 52 (40–65) | 73 (42%) | 5 (2.9%) | 926 (84.3%) | 45 (34-57) | 386 (42%) | 1 (0.1%) |
| Huang et al. [23] | Wuhan, China | 41 | 13 (31.7%) | 49 (41-61) | 2 (15%) | 3 (23.1%) | 28 (68.3%) | 49 (41-57.5) | 15 (53.6%) | 0 (0%) |
| Zhang Guqin et al., [24] | Wuhan, China | 221 | 55 (24.9%) | 62 (52-74) | 20 (36.4%) | 8 (14.5%) | 166 (75.1%) | 51 (36-64.3) | 93 (56%) | 2 (1.2%) |
| Yao et al., [25] | Dabieshan, China | 108 | 25 (23.1%) | - | 12 (48%) | 9 (36%) | 83 (76.9%) | 50.0 (34.0 56.0) |
53 (63.9%) | 7 (8.4%) |
| Aggarwal et al., [26] | Iowa, USA | 16 | 8 (50%) | 67 (38-70) | 3 (38%) | 8 (100%) | 8 (50%) | 68.5 (41-95) | 1 (13%) | 3 (37.5%) |
| Wang D et al., [27] | Wuhan, China | 138 | 36 (26.1%) | 66 (57-78) | 14 (38.9) | 3 (8.3%) | 102 (73.9%) | 51 (37-62) | 49 (48%) | 2 (1.9%) |
| Chen G et al., [28] | Wuhan, China | 21 | 11 (52.4%) | 61 (56.5-66) | 1 (9.1%) | 2 (18.2%) | 10 (47.6%) | 52 (42.8-56) | 3 (30%) | 0 (0%) |
| Hong et al., [29] | Daegu, South Korea | 98 | 13 (13.2%) | 63.2±10.1 | 7 (53.8%) | 8 (61.5%) | 85 (86.8%) | 54.2±17.7 | 53 (62.4%) | 1 (1.2%) |